2025: Cure Parkinson's research highlights from the last year and insights for the year ahead
2024 was another busy year for the research team at Cure Parkinson’s; from the results publication of the phase 2 clinical trial of lixisenatide to the funding of new pre-clinical projects, Cure Parkinson’s has not stopped in its mission to slow, stop or reverse Parkinson’s....
Learn more
Webinar: Rallying to the Challenge Meeting 2021
‘Rallying to the Challenge’ is a meeting designed for and by people with Parkinson’s, advocates and care partners to explore how the Parkinson’s community can impact and accelerate research. Each year the meeting takes an aspect of Parkinson’s research and discusses how people living with…
Webinar – Genetic markers and the progression of Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. This webinar discusses recent publications around the theme of genetic markers and the progression of Parkinson’s. The panel, chaired by Van Andel Institute’s Professor Patrik Brundin, comprises: Professor Mark Cookson from NIH;…
PD Avengers webinar hosted by Cure Parkinson’s: Women with Parkinson’s
Can meeting the needs of women living with Parkinson’s unlock new treatments to better manage, slow, stop or even cure Parkinson’s? Re-watch our recent webinar.
Van Andel Institute: Virtual public lecture series
This informative event featured presentations and a Q&A session with international Parkinson’s disease experts including Cure Parkinson’s Director of Research, Dr Richard Wyse and Deputy Director of Research, Dr Simon Stott.
Webinar – Young Onset Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. The latest instalment of our interactive webinar series, in partnership with The Journal of Parkinson’s Disease discusses recent publications around the theme of Young Onset Parkinson’s. The eminent panel, once again chaired…